Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2022 June;113(3) > Minerva Medica 2022 June;113(3):449-59

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Free accessfree

Minerva Medica 2022 June;113(3):449-59

DOI: 10.23736/S0026-4806.22.08001-6

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Treatable traits in COPD patients

Francesco NUCERA 1, Andrea BIANCO 2, Teresa DAVID 3, Ilaria SALVATO 1, Ian M. ADCOCK 4, Gaetano CARAMORI 1

1 Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Messina, Italy; 2 Department of Translational Medical Sciences, L. Vanvitelli University of Campania, Naples, Italy; 3 Unit of Emergency Medicine, G. Martino University Hospital, Messina, Italy; 4 Section of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK



There is no justification for a therapeutic nihilism in clinical practice because current management (pharmacological and non-pharmacological) of the patients with chronic obstructive pulmonary disease according to treatable traits is effective in decreasing their respiratory symptoms, increasing their exercise tolerance and capacity, improving their quality of life, preventing (and treating) many of their exacerbations and decreasing their mortality.


KEY WORDS: Pulmonary disease, chronic obstructive; Smoking cessation; SARS-CoV-2; Glucocorticoids; Bronchodilator agents

top of page